BCYC
Bicycle Therapeutics Ltd
4.00$
+18.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.4% | +266.3% | -52.1% | -71.4% | +38.6% | +169.1% | -70.7% | +301.8% | +308.7% | -98.2% | -29.1% | – | |
| – | -98.9% | -0.7% | -0.9% | +2,680.3% | +22.8% | +2.1% | +24.0% | – | – | – | – | – | |
| – | -0.4% | +266.3% | -52.1% | -559.1% | – | – | – | – | +308.7% | -98.2% | -29.1% | – | |
| – | +12.1% | -22.0% | +14.9% | +20.5% | +3.1% | +18.6% | +20.3% | -17.7% | -11.4% | -5.5% | -15.8% | – | |
| – | -3.3% | +9.3% | -2.4% | +13.8% | +15.1% | +0.5% | -8.9% | -1.1% | +9.6% | -15.7% | -20.2% | – | |
| – | +6.1% | -14.0% | +9.3% | -62.7% | -26.7% | +49.7% | -19.3% | +317.9% | -6.0% | -8.5% | -17.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.7% | +0.1% | +0.4% | -96.0% | +57.6% | -1.9% | +5.9% | -18.5% | +29.5% | -15.8% | -8.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -85.9% | -209.4% | – | -3,098.3% | – | – | – | – | +517.1% | -86.4% | -47.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.